Raj Manchanda
Technik-/Wissenschafts-/F&E-Leiter bei NEUMORA THERAPEUTICS, INC.
Aktive Positionen von Raj Manchanda
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| NEUMORA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2023 | - |
Karriereverlauf von Raj Manchanda
Ehemalige bekannte Positionen von Raj Manchanda
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Anokion US, Inc. | Corporate Officer/Principal | 01.05.2019 | 01.07.2023 |
| KORRO BIO, INC. | Corporate Officer/Principal | 01.02.2016 | 01.10.2018 |
Ausbildung von Raj Manchanda
| Yale University | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NEUMORA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Frequency Therapeutics, Inc.
 Frequency Therapeutics, Inc. BiotechnologyHealth Technology Frequency Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the business of developing therapeutics to activate a person's innate regenerative potential to restore function. The firm is also involved in creating and commercializing therapeutics to potentially transform the lives of individuals by repairing or reversing damage done to cells, tissue, and organs. The company was founded by Robert S. Langer, David L. Lucchino, Christopher R. Loosey, and Will J. McLean on November 13, 2014 and is headquartered in Lexington, MA. | Health Technology |
| Anokion US, Inc. |
- Börse
- Insiders
- Raj Manchanda
- Erfahrung
